T-cell receptor Vβ gene usage in CSF lymphocytes in X-linked adrenoleukodystrophy

Journal of Molecular Recognition

Volumn 18, Issue 3, 2005, Pages 254-261

  Picard, Fabienne ^a,b   Guidoux, Sylvie ^c   Martin, Thierry ^a   Aubourg, Patrick ^c   Pasquali, Jean Louis ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

Cerebrospinal fluid; T cell receptor usage; X linked adrenoleukodystrophy

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR;

ADRENOLEUKODYSTROPHY; ADULT; ARTICLE; CEREBROSPINAL FLUID; FEMALE; GENE DOSAGE; GENETICS; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SOUTHERN BLOTTING; T LYMPHOCYTE;

ADRENOLEUKODYSTROPHY; ADULT; BASE SEQUENCE; BLOTTING, SOUTHERN; FEMALE; GENE DOSAGE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PHENOTYPE; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SEQUENCE HOMOLOGY, NUCLEIC ACID; T-LYMPHOCYTES;

EID: 18944373432     PISSN: 09523499     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmr.727     Document Type: Article

References (43)

1. Aubourg P, Sack GH Jr, Meyers DA, Lease JJ, Moser HW. 1987. Linkage of adrenoleukodystrophy to a polymorphic DNA probe. Ann. Neurol. 21: 349-352.
2. Babbe H, Roers A, Waisman A, Lassmann H, Goebels N, Hohlfeld R, Friese M, Schroder R, Deckert M, Schmidt S, Ravid R, Rajewsky K. 2000. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192: 393-404.
3. Bernheimer H, Budka H, Müller P. 1983. Brain tissue immunoglobulins in adrenoleukodystrophy: a comparison with multiple sclerosis and systemic lupus erythematosus. Acta Neuropathol. Berl. 59: 95-102.
4. Boutin B, Matsuguchi L, Lebon P, Ponsot G, Arthuis C. 1989. Immunohistochemical analysis of brain macrophages in adrenoleukodystrophy. Neuropediatrics 20: 202-206.
5. Braun A, Ambach H, Kammerer S, Rolinski B, Stockler S, Rabl W, Gartner J, Zierz S, Roscher AA. 1995. Mutations in the gene for X-linked adrenoleukodystrophy in patients with different clinical phenotypes. Am. J. Hum. Genet. 56: 854-861.
6. Cartier N, Lopez J, Moullier P, Rocchiccioli F, Rolland M, Jorge P, Mosser J, Mandel J, Bougneres P, Danos O, Aubourg P. 1995. Retroviral-mediated gene transfer corrects very-long-chain fatty acid metabolism in adrenoleukodystrophy fibroblasts. Proc. Natl Acad. Sci. USA 92: 1674-1678.
7. Contreras M, Mosser J, Mandel JL, Aubourg P, Singh I. 1994. Protein coded by the X-adrenoleukodystrophy gene is a peroxisomal integral membrane protein. FEBS Lett. 344: 211-215.
8. Davis MM, Bjorkman PJ. 1988. T-cell antigen receptor genes and T-cell recognition. Nature 334: 395-402.
9. Di Biase A, Merendino N, Avellino C, Cappa M, Salvati S. 2001. Th 1 cytokine production by peripheral blood mononuclear cells in X-linked adrenoleukodystrophy. J. Neurol. Sci. 182: 161-165.
10. Dubois-Dalcq M, Feigenbaum V, Aubourg P. 1999. The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder. Trends Neurosci. 22: 4-12.
11. Fanen P, Guidoux S, Sarde C, Mandel JL, Goossens M, Aubourg P. 1994. Identification of mutations in the putative ATP-binding domain of the adrenoleukodystrophy gene. J. Clin. Invest. 94: 516-520.
12. Feeney AJ. 1990. Lack of N regions in fetal and neonatal mouse immunoglobulin V-D-J junctional sequences. J. Exp. Med. 172: 1377-1390.
13. Feigenbaum V, Lombard-Platet G, Guidoux S, Sarde CO, Mandel JL, Aubourg P. 1996. Mutational and protein analysis of patients and heterozygous women with X-linked adrenoleukodystrophy. Am. J. Hum. Genet. 58: 1135-1144.
14. Forss-Petter S, Werner H, Berger J, Lassmann H, Molzer B, Schwab MH, Bernheimer H, Zimmermann F, Nave KA. 1997. Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice. J. Neurosci. Res. 50: 829-843.
15. Fuchs S, Sarde CO, Wedemann H, Schwinger E, Mandel JL, Gal A. 1994. Missense mutations are frequent in the gene for X-chromosomal adrenoleukodystrophy (ALD). Hum. mol. Genet. 3: 1903-1905.
16. Gilfillan S, Dierich A, Lemeur M, Benoist C, Mathis D. 1993. Mice lacking TdT: mature animals with an immature lymphocyte repertoire. Science 26: 1175-1178.
17. Goebels N, Hofstetter H, Schmidt S, Brunner C, Wekerle H, Hohlfeld R. 2000. Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects-epitope spreading versus clonal persistence. Brain 123: 508-518.
18. Griffin DE, Moser HW, Mendoza Q, Moench TR, O'Toole S, Moser AB. 1985. Identification of the inflammatory cells in the central nervous system of patients with adrenoleukodystrophy. Ann. Neurol. 18: 660-664.
19. Ito M, Blumberg BM, Mock DJ, Goodman AD, Moser AB, Moser HW, Smith KD, Powers JM. 2001. Potential environmental and host participants in the early white matter lesion of adrenoleukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation. J. Neuropathol. Exp. Neurol. 60: 1004-1019.
20. Kannagi R, Nudelman E, Hakomori SI. 1982. Possible role of ceramide in defining structure and function of membrane glycolipids. Proc. Natl Acad. Sci. USA 79: 3470-3474.
21. Kishimoto Y, Moser HW, Suzuki K. 1985. Adrenoleukodystrophy. In Handbook of Neurochemistry, Abel Lajtha (ed.). Plenum Press: New York; 125-151.
22. Kobayashi T, Shinnoh N, Kondo A, Yamada T. 1997. Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism. Biochem. Biophys. Res. Commun. 232: 631-636.
23. Korenke GC, Christen H-J, Kruse B, Hunneman DH, Hanefeld F. 1997. Progression of X-linked adrenoleukodystrophy under interferon-β therapy. J. Inner. Metab. Dis. 20: 59-66.
24. Kumar AJ, Rosenbaum AE, Naidu S, Wener L, Citrin CM, Lindenberg R, Kim WS, Zinreich SJ, Molliver ME, Mayberg HS, et al. 1987. Adrenoleukodystrophy: correlating MR imaging with CT. Radiology 165: 497-504.
25. Legras F, Martin T, Knapp AM, Pasquali JL. 1994. Infiltrating T cells from patients with primary Sjögren's syndrome express restricted or unrestricted T cell receptor Vβ regions depending on the stage of the disease. Eur. J. Immunol. 24:181-185.
26. Lieber MR. 1992. The mechanism of V(D)J recombination: a balance of diversity, specificity and stability. Cell 70: 873-876.
27. Ligtenberg MJL, Kemp S, Sarde CO, van Geel BM, Kleijer WJ, Barth PG, Mandel JL, van Oost BA, Bolhuis PA. 1995. Spectrum of mutations in the gene encoding the adrenoleukodystrophy protein. Am. J. Hum. Genet. 56: 44-50.
28. Liu LX, Janvier K, Berteaux-Lecellier V, Cartier N, Benarous R, Aubourg P. 1999. Homo- and heterodimerization of peroxisomal ATP-binding cassette half-transporters. J. Biol. Chem. 274: 32738-32743.
29. Loes DJ, Hite S, Moser H, Stillman AE, Shapiro E, Lockman L, Latchaw RE, Krivit W. 1994. Adrenoleukodystrophy: a scoring method for brain MR observations. Am. J. Neuroradiol. 15: 1761-1766.
30. Lu JF, Lawler AM, Watkins PA, Powers JM, Moser AB, Moser HW, Smith KD. 1997. A mouse model for X-linked adrenoleukodystrophy. Proc. Natl Acad. Sci. USA 94: 9366-9371.
31. Maniatis T, Fritsch EF, Sambrook J. 1989. Extraction, purification and analysis of messenger RNA from eukaryotic cells. In Molecular Cloning - a Laboratory Manual, Fords N, Nolan C, Ferguson M (eds). Cold Spring Harbor Laboratory Press: New York; 7.12-7.15.
32. McGuinness MC, Powers JM, Bias WB, Schmeckpeper BJ, Segal AH, Gowda VC, Wesselingh SL, Berger J, Griffin DE, Smith KD. 1997. Human leukocyte antigens and cytokine expression in cerebral inflammatory demyelinative lesions of X-linked adrenoleukodystrophy and multiple sclerosis. J. Neuroimmunol. 75: 174-182.
33. Moser HW. 1997. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 120: 1485-1508.
34. Mosser J, Douar AM, Sarde CO, Kioschis P, Feil R, Moser H, Poustka AM, Mandel JL, Aubourg P. 1993. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361: 726-730.
35. Mosser J, Lutz Y, Stoeckel ME, Sarde CO, Kretz C, Douar AM, Lopez J, Aubourg P, Mandel JL. 1994. The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. Hum. Mol. Genet. 3: 265-271.
36. Muraro PA, Wandinger KP, Bielekova B, Gran B, Marques A, Utz U, McFarland HF, Jacobson S, Martin R. 2003. Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders. Brain 126: 20-31.
37. Picard F, Martin T, Legras F, Lioure B, Pasquali JL. 1993. Molecular analysis of T-cell receptor Vβ chains of human T-cell chronic lymphocytic leukemia does not show intraclonal variability: implications for immunotherapy. Blood 82: 2152-2156.
38. Powers JM, Liu Y, Moser AB, Moser HW. 1992. The inflammatory myelinopathy of adrenoleukodystrophy: cells, effector molecules and pathogenetic implications. J. Neuropathol. Exp. Neurol. 6: 630-643.
39. Schaumburg HH, Powers JM, Raine CS, Suzuki K, Richardson EP Jr. 1975. Adrenoleukodystrophy: a clinical and pathological study of 17 cases. Arch. Neurol. 32: 577-591.
40. Singh I, Moser A, Goldfischer S, Moser HW. 1984. Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy. Proc. Natl Acad. Sci. USA 81: 4203-4207.
41. Smith KD, Kemp S, Braiterman LT, Lu JF, Wei HM, Geraghty M, Stellen G, Bergin JS, Pevsner J, Walkins PA. 1999. X-linked adrenoleukodystrophy: genes, mutations, and phenotypes. Neurochem. Res. 24: 521-535.
42. Steinberg SJ, Kemp S, Braiterman LT, Watkins PA. 1999. Role of very-long-chain acyl-coenzyme A synthetase in X-linked adrenoleukodystrophy. Ann. Neurol. 46: 409-412.
43. Wilichowski E, Ohlenbusch A, Korenke GC, Hunneman DH, Hanefeld F. 1998. Identical mitochondrial DNA in monozygotic twins with discordant adrenoleukodystrophy phenotype. Ann. Neurol. 43: 835-836.